98 related articles for article (PubMed ID: 26678281)
1. Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).
Verma A; Abisheganaden J; Light RW
Lung; 2016 Feb; 194(1):147-53. PubMed ID: 26678281
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal pleural infection in a recurrent pleural effusion: a case report.
Wee ACR; Seet JE; Venkatalacham J; Tan SK
Respirol Case Rep; 2018 Apr; 6(3):e00294. PubMed ID: 29796274
[TBL] [Abstract][Full Text] [Related]
3. Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects.
Ghaderi B; Amini S; Maroofi F; Jalali C; Javanmardi M; Roshani D; Abdi M
Iran J Cancer Prev; 2016 Jun; 9(3):e5069. PubMed ID: 27703646
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.
Ding H; Liu J; Xue R; Zhao P; Qin Y; Zheng F; Sun X
Biomed Rep; 2014 Sep; 2(5):765-769. PubMed ID: 25054025
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).
Verma A; Dagaonkar RS; Marshall D; Abisheganaden J; Light RW
Can Respir J; 2016; 2016():7348239. PubMed ID: 28070157
[No Abstract] [Full Text] [Related]
6. Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.
Liu YL; Wu YB; Zhai K; Wang XJ; Shi HZ
Sci Rep; 2016 Jan; 6():19424. PubMed ID: 26783266
[TBL] [Abstract][Full Text] [Related]
7. The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions.
Wang J; Liu J; Xie X; Shen P; He J; Zeng Y
BMC Pulm Med; 2017 Dec; 17(1):168. PubMed ID: 29202740
[TBL] [Abstract][Full Text] [Related]
8. Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions.
Korczyński P; Mierzejewski M; Krenke R; Safianowska A; Light RW
Pol Arch Intern Med; 2018 Jun; 128(6):354-361. PubMed ID: 29968696
[TBL] [Abstract][Full Text] [Related]
9. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing malignant pleural effusion using clinical and analytical parameters.
Pan Y; Bai W; Chen J; Mao Y; Qian X; Xu K; Tang S; Zhang J; Chen C; Chen J; Hu X
J Clin Lab Anal; 2019 Feb; 33(2):e22689. PubMed ID: 30390322
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.
Zhao T; Zhang J; Zhang X; Wang C
BMC Pulm Med; 2024 May; 24(1):241. PubMed ID: 38750432
[TBL] [Abstract][Full Text] [Related]
12. Malignant pleural disease.
Piggott LM; Hayes C; Greene J; Fitzgerald DB
Breathe (Sheff); 2023 Dec; 19(4):230145. PubMed ID: 38351947
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma.
Xu K; Wu X; Chen L; Xie J; Hua X; Chen M; Jiang Y; Liu H; Zhang F; Lv T; Song Y; Zhan P
Transl Lung Cancer Res; 2023 Sep; 12(9):1887-1895. PubMed ID: 37854163
[TBL] [Abstract][Full Text] [Related]
14. LDH/ADA ratio in pleural fluid for the diagnosis of infectious pleurisy.
Núñez-Jurado D; Rodríguez-Martín I; Guerrero JM; Santotoribio JD
Clin Exp Med; 2023 Dec; 23(8):5201-5213. PubMed ID: 37747590
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion.
Li T; Tian P; Huang Q; Zeng H; Wei Q; Li Y
Clin Respir J; 2023 Nov; 17(11):1158-1168. PubMed ID: 37723659
[TBL] [Abstract][Full Text] [Related]
16. Novel clinical radiomic nomogram method for differentiating malignant from non-malignant pleural effusions.
Han R; Huang L; Zhou S; Shen J; Li P; Li M; Wu X; Wang R
Heliyon; 2023 Jul; 9(7):e18056. PubMed ID: 37539225
[TBL] [Abstract][Full Text] [Related]
17. Differentiating between tuberculous and non-tuberculous pleural effusions using the pleural fluid ratio of 10× adenosine deaminase/lactate dehydrogenase.
Li Y; Chen Z; Yang P; Duan H; He J; Gong L; Zhao L
J Thorac Dis; 2023 May; 15(5):2627-2635. PubMed ID: 37324069
[TBL] [Abstract][Full Text] [Related]
18. Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion.
Huang JH; Chen H; Zhang ZC; Gu J; Yan L; Jiang MP; Zheng WQ; Hu ZD; Jiang TW
BMC Pulm Med; 2023 Jun; 23(1):198. PubMed ID: 37286973
[TBL] [Abstract][Full Text] [Related]
19. A Novel Clinical Prognostic Model for Breast Cancer Patients with Malignant Pleural Effusion: Avoiding Chemotherapy in Low-Risk Groups?
Wang Y; Zhou T; Zhao S; Li N; Sun S; Li M
Cancer Manag Res; 2023; 15():409-422. PubMed ID: 37197007
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
